GR3035292T3 - 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders. - Google Patents

3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders.

Info

Publication number
GR3035292T3
GR3035292T3 GR20010400106T GR20010400106T GR3035292T3 GR 3035292 T3 GR3035292 T3 GR 3035292T3 GR 20010400106 T GR20010400106 T GR 20010400106T GR 20010400106 T GR20010400106 T GR 20010400106T GR 3035292 T3 GR3035292 T3 GR 3035292T3
Authority
GR
Greece
Prior art keywords
benzimidazole
oxo
carboxyl
pct
nervous system
Prior art date
Application number
GR20010400106T
Other languages
English (en)
Inventor
Bruce E Maryanoff
David F Mccomsey
Ho Winston
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of GR3035292T3 publication Critical patent/GR3035292T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR20010400106T 1992-08-19 2001-01-24 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders. GR3035292T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93217692A 1992-08-19 1992-08-19
PCT/US1993/007794 WO1994004532A1 (en) 1992-08-19 1993-08-18 3-oxo-pyrido(1,2-a^_)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a^_)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders

Publications (1)

Publication Number Publication Date
GR3035292T3 true GR3035292T3 (en) 2001-04-30

Family

ID=25461897

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400106T GR3035292T3 (en) 1992-08-19 2001-01-24 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders.

Country Status (16)

Country Link
US (2) US5639760A (el)
EP (1) EP0656002B1 (el)
JP (1) JP3463935B2 (el)
KR (1) KR100262762B1 (el)
AT (1) ATE197455T1 (el)
AU (1) AU679938B2 (el)
BR (1) BR9306929A (el)
CA (1) CA2142700C (el)
DE (1) DE69329654T2 (el)
DK (1) DK0656002T3 (el)
ES (1) ES2153842T3 (el)
GR (1) GR3035292T3 (el)
HU (1) HU221369B1 (el)
NZ (1) NZ255821A (el)
PT (1) PT656002E (el)
WO (1) WO1994004532A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0935598T1 (en) * 1996-10-07 2004-04-30 Ortho-Mcneil Pharmaceutical, Inc. 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
ES2212081T3 (es) * 1996-10-07 2004-07-16 Ortho-Mcneil Pharmaceutical, Inc. Derivados de 3-oxo-pirido(1,2-a)bencimidazol-4-carboxamida que contienen 5-heteroatomos sustituidos con alquilo en el tratamiento de trastornos del sistema nervioso central.
US5922731A (en) * 1997-06-30 1999-07-13 Ortho Pharmaceutical Corporation 5- (heteroaryl)alkyl!-3-oxo-pyrido 1,2-a!benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders
DK1023291T3 (da) * 1997-10-07 2004-10-04 Ortho Mcneil Pharm Inc Dipyridoimidazolderivater, som er egnet til behandling af lidelser i centralnervesystemet
AU2003204221B2 (en) * 1997-10-07 2006-07-27 Ortho-Mcneil Pharmaceutical, Inc. Dipyridoimidazolderivatives useful in treating central nervous system disorders
DE69810340T2 (de) * 1997-10-07 2003-10-30 Ortho Mcneil Pharm Inc Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
AU2653499A (en) * 1998-02-04 1999-08-23 Neurogen Corporation Oxo-dipyridoimidazole-carboxamides: gaba brain receptor ligands
ES2246090T3 (es) * 1998-08-25 2006-02-01 Neurogen Corporation Oxo-piridoimidazol-carboxamidas: ligandos del receptor cerebral gaba.
US6177569B1 (en) 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
DE60018274T2 (de) * 1999-05-06 2005-08-04 Neurogen Corp., Branford Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
ATE321044T1 (de) * 1999-08-02 2006-04-15 Ortho Mcneil Pharm Inc C-6 ringsubstituierte pyrido(1,2- a)benzimidazolderivate zur behandlung von störungen des zentralen nervensystems
GB0203058D0 (en) 2002-02-09 2002-03-27 Bp Chem Int Ltd Production of olefins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663934B1 (fr) * 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
AU5080893A (en) 1994-03-15
HU9500476D0 (en) 1995-04-28
US6218384B1 (en) 2001-04-17
BR9306929A (pt) 1999-01-12
DE69329654T2 (de) 2001-03-15
EP0656002B1 (en) 2000-11-08
JP3463935B2 (ja) 2003-11-05
ATE197455T1 (de) 2000-11-11
CA2142700A1 (en) 1994-03-03
PT656002E (pt) 2001-02-28
HUT72654A (en) 1996-05-28
WO1994004532A1 (en) 1994-03-03
AU679938B2 (en) 1997-07-17
DE69329654D1 (de) 2000-12-14
JPH08500594A (ja) 1996-01-23
DK0656002T3 (da) 2000-11-27
EP0656002A1 (en) 1995-06-07
HU221369B1 (en) 2002-09-28
ES2153842T3 (es) 2001-03-16
NZ255821A (en) 1996-10-28
US5639760A (en) 1997-06-17
KR100262762B1 (ko) 2000-08-01
CA2142700C (en) 2007-01-09

Similar Documents

Publication Publication Date Title
HU9501752D0 (en) Application of carbamazepine and oxacarbazepine in the treatment of neurological lesions related to traumatic injuries
GR3035292T3 (en) 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders.
SI0751129T1 (en) Substituted dihydrodibenzo(b,f)azepines, method for their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them
IL133825A0 (en) Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
IL114599A (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containg them
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ATE216390T1 (de) Neue verbindungen
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
ES2134929T3 (es) Derivados de pirrolo-piridina como ligandos para receptores de dopamina.
ATE205480T1 (de) 2,5-dioxo-2,5-dihydro-1h-benz(b)azepine als nmda rezeptor antagonisten
FI19992037A (fi) Menetelmä atsepinonien valmistamiseksi
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
BG103687A (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
HU9502495D0 (en) Xanthine derivatives as adenosine a1 receptor antagonists
PL316870A1 (en) Derivatives of 5-heterocyclo 1,5-benzodiazepine
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
DK0648117T3 (da) Lægemiddel til at forebygge udvikling af tolerance ved behandling med benzodiazepin-receptor-bindende aktive forbindelser
DK0691846T3 (da) Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet
ATE112256T1 (de) 9-amino-2-phenylbicyclo(3.3.1>nonane und 9-amino- 2-phenylbicyclo(3.3.1>-non-2-ene und diese enthaltende therapeutische mittel.
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
ATA57894A (de) Mittel zur behandlung von osteoporose
MX9804631A (es) Antagonistas quinazolin-4-ona del ampa.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees